8 October 2026
Latham & Watkins Advises on Rocket Pharmaceuticals’ Growth Facility
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hai Pham Lead | Latham & Watkins LLP | Partner | finance | Not stated |
| Haim Zaltzman Lead | Latham & Watkins LLP | Partner | finance | Not stated |
| Jake Ibrahim | Latham & Watkins LLP | Associate | finance | Not stated |
| Omar Adel | Latham & Watkins LLP | Associate | finance | Not stated |
| Eric Cho | Latham & Watkins LLP | Partner | tax | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | healthcare and data privacy | Not stated |
| Jennifer Yoo | Latham & Watkins LLP | Partner | healthcare and data privacy | Not stated |
| Eric Rice | Latham & Watkins LLP | Partner | convertibles | Not stated |
| Reza Mojtabaee-Zamani | Latham & Watkins LLP | Partner | convertibles | Not stated |
| Robertson Dorsett | Latham & Watkins LLP | Associate | convertibles | Not stated |
| Drew Capurro | Latham & Watkins LLP | Partner | corporate | Not stated |
| Gregory Van Buiten | Latham & Watkins LLP | Associate | corporate | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m (US$150 million)
- What the figure measures
- Facility amount
- Client
- Hercules Capital, Inc.Lenders
- Counterparties
- Rocket Pharmaceuticals, Inc. (Borrower)